| COVID-19 |
1 |
1 |
| Schizophrenia |
0 |
0.99 |
| Antipsychotics |
0 |
0.82 |
| Mental Illness |
0 |
0.98 |
| Bipolar Disorder |
0 |
0.31 |
| COVID-19 Vaccine |
0 |
0.29 |
| Health Care Quality, Access, and Evaluation |
0 |
0.97 |
| Immunization |
0 |
0.24 |
| Schizoaffective Disorder |
0 |
0.24 |
| Social Determinants of Health |
0 |
0.19 |
| Cardiovascular disease |
0 |
0.12 |
| Electronic Medical Record |
0 |
0.12 |
| Insurance |
0 |
0.12 |
| New York |
0 |
0.12 |
| Pathogenesis |
0 |
0.12 |
| Socioeconomics |
0 |
0.12 |
| Pneumonia |
0 |
0.11 |
| Electronic Health Record (EHR) and Healthcare Technology |
0 |
0.1 |
| Cardiovascular Risk Management |
0 |
0.06 |
| Revenue and Practice Management |
0 |
0.06 |
| Vaccines |
0 |
0.06 |